Science Explorer Back to mapMap
Discussion
Researcher · Clearview Cancer Institute · United States

Marshall T. Schreeder

Marshall T. Schreeder publishes mostly in Genetics, Oncology and Pathology and Forensic Medicine, on topics such as Chronic Lymphocytic Leukemia Research, Lymphoma Diagnosis and Treatment and Immunodeficiency and Autoimmune Disorders.

OpenAlex
World rank
#905,525
of 7,710,434 ranked researchers
Rank in United States
#298,548
of 1,627,098
Works
130
Citations
2.9k
Citations per work
22.2
h-index
30
i10-index 67Top 13% in Genetics (Medicine)
Marshall T. Schreeder

What does Marshall T. Schreeder research?

Marshall T. Schreeder's work is mostly in Medicine (47%), Biochemistry, Genetics and Molecular Biology (8%), Immunology and Microbiology (7%).

Health Sciences: 61 works · 47.1% of their workMedicine: 61 works · 47.1% of their workGenetics: 20 works · 15.6% of their workOncology: 20 works · 15.3% of their workPathology and Forensic Medicine: 13 works · 10.3% of their workHepatology: 8 works · 5.9% of their workEverything else: 48 works · 37.3% of their workLife Sciences: 20 works · 15.6% of their workBiochemistry, Genetics and Molecular Biology: 11 works · 8.2% of their workMolecular Biology: 11 works · 8.2% of their workImmunology and Microbiology: 10 works · 7.4% of their workImmunology: 10 works · 7.4% of their workTHEIR WORKMarshall T.Schreeder130works
Life Sciences16%Health Sciences47%

Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.

The fields and subfields, with their numbers
    1. Medicine6147.1%
  2. Everything else4837.3%
    1. Biochemistry, Genetics and Molecular Biology118.2%
    2. Immunology and Microbiology107.4%
  1. 1Genetics16% of their works
  2. 2Oncology15% of their works
  3. 3Pathology and Forensic Medicine10% of their works
  4. 4Molecular Biology8% of their works
  5. 5Immunology7% of their works
  6. 6Hepatology6% of their works

Research topics

Which keywords describe Marshall T. Schreeder's research?

The keywords of their largest research topics: Rituximab, Prognostic Factors, Chronic Lymphocytic Leukemia, Genomic Aberrations, Classification, Lymphoma, Genetic Mutations and Primary Immunodeficiency.

Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.

All 18 words, with their numbers
  1. Rituximab832 topics
  2. Prognostic Factors733 topics
  3. Chronic Lymphocytic Leukemia511 topic
  4. Genomic Aberrations511 topic
  5. Classification321 topic
  6. Lymphoma321 topic
  7. Genetic Mutations151 topic
  8. Primary Immunodeficiency151 topic
  9. Fc Receptors131 topic
  10. Genomic Profiles131 topic
  11. Small-Cell Lung Cancer131 topic
  12. Therapeutic Antibodies131 topic
  13. Acute Lymphoblastic Leukemia91 topic
  14. BCR-ABL91 topic
  15. Chemotherapy-Induced Peripheral Neuropathy91 topic
  16. Childhood Cancer91 topic
  17. Imatinib91 topic
  18. Taxanes91 topic

Where does Marshall T. Schreeder work?

Marshall T. Schreeder's main affiliation in the publication record is Clearview Cancer Institute, United States.

How many publications and citations does Marshall T. Schreeder have?

OpenAlex counts 130 works and 2,882 citations for Marshall T. Schreeder, an h-index of 30, ranking #905,525 of 7,710,434 researchers worldwide on the quality score.

Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.

Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.

Discussion

Ask a question or share a note about Marshall T. Schreeder. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.